Publications found:
54,544
Sort by:
2017-2021 France Enteric Disease Market: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technologies
US$ 1,980.00
... report from VPGMarketResearch.com presents detailed analysis of the French Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium ... technologies and products; and- Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology ...
January 2017
322 pages
2017-2021 Germany Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
US$ 1,755.00
... report from VPGMarketResearch.com presents detailed analysis of the German Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza ... technologies and products; and Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology ...
January 2017
283 pages
2017-2021 Germany Enteric Disease Market: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
US$ 1,980.00
... report from VPGMarketResearch.com presents detailed analysis of the German Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium ... technologies and products; and Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology ...
January 2017
322 pages
2017-2021 Italy Enteric Disease Market: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
US$ 1,980.00
... report from VPGMarketResearch.com presents detailed analysis of the Italian Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium ... technologies and products; and- Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology ...
January 2017
322 pages
2017-2021 Japan Enteric Disease Market: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
US$ 2,340.00
... report from VPGMarketResearch.com presents detailed analysis of the Japanese Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium ... technologies and products; and Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology ...
January 2017
322 pages
2017-2021 Spain Enteric Disease Market: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
US$ 1,980.00
... report from VPGMarketResearch.com presents detailed analysis of the Spanish Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium ... technologies and products; and Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology ...
January 2017
322 pages
2017-2021 UK Enteric Disease Market: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
US$ 1,980.00
... -page report from VPGMarketResearch.com presents detailed analysis of the UK Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium ... technologies and products; and Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology ...
January 2017
322 pages
2017-2021 US Enteric Disease Market: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
US$ 3,465.00
... -page report from VPGMarketResearch.com presents detailed analysis of the US Enteric Diseases market, including sales forecasts and supplier shares for Campylobacter, Cryptosporidium ... technologies and products; and Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology ...
January 2017
322 pages
2017-2021 France Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
US$ 1,755.00
... report from VPGMarketResearch.com presents detailed analysis of the French Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza ... technologies and products; and Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology ...
January 2017
282 pages
2017-2021 Italy Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
US$ 1,755.00
... report from VPGMarketResearch.com presents detailed analysis of the Italian Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza ... technologies and products; and Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology ...
January 2017
281 pages
2017-2021 Japan Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
US$ 2,160.00
... report from VPGMarketResearch.com presents detailed analysis of the Japanese Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza ... technologies and products; and Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology ...
January 2017
282 pages
2017-2021 Spain Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
US$ 1,755.00
... report from VPGMarketResearch.com presents detailed analysis of the Spanish Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza ... technologies and products; and Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology ...
January 2017
281 pages
2017-2021 UK Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
US$ 1,755.00
... -page report from VPGMarketResearch.com presents detailed analysis of the UK Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza ... technologies and products; and Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology ...
January 2017
281 pages
2017-2021 US Respiratory Disease Market: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Supplier Shares, Competitive Strategies, Country Volume and Sales Segment Forecasts, Technology Trends, Instrumentation Review
US$ 3,240.00
... -page report from VPGMarketResearch.com presents detailed analysis of the US Respiratory Diseases market, including sales forecasts and supplier shares for Adenovirus, Influenza ... technologies and products; and Analyzes emerging opportunities, alternative market penetration strategies, market entry barriers/risks, and strategic planning issues. Methodology ...
January 2017
283 pages
2017-2021 US HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares, Country Segment Volume and Sales Forecasts
US$ 1,305.00
... and sale forecasts for HIV-1/2/combo, HIV Ag, NAT, Western Blot and other confirmatory assays performed in the following market segments: Hospitals ... sales and market Share estimates for major suppliers of AIDS testing including Abbott, bioMerieux, Bio-Rad, Grifols, Ortho Clinical Diagnostics, and Roche ...
January 2017
2017-2021 UK HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares, Country Segment Volume and Sales Forecasts
US$ 1,305.00
... and sale forecasts for HIV-1/2/Combo, HIV Ag, NAT, Western Blot and other confirmatory assays performed in the following market segments: Hospitals ... sales and market share estimates for major suppliers of AIDS tests, including Abbott, bioMerieux, Bio-Rad, Grifols, Ortho Clinical Diagnostics/J&J, Roche, and ...
January 2017
2017-2021 Spain HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares, Country Segment Volume and Sales Forecasts
US$ 1,305.00
... and sale forecasts for HIV-1/2/Combo, HIV Ag, NAT, Western Blot and other confirmatory assays performed in the following market segments: Hospitals ... and market share estimates for major suppliers of AIDS tests, including Abbott, Biokit, bioMerieux, Bio-Rad, Fujirebio, Grifols, Ortho Clinical Diagnostics/J&J, ...
January 2017
2017-2021 Japan HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares, Country Segment Volume and Sales Forecasts
US$ 1,305.00
... sale forecasts for HIV-1/2/Combo, HIV Ag, NAT, Western Blot and other confirmatory assays performed in the following market segments: Hospitals ... sales and market share estimates for major suppliers of AIDS tests, including Abbott, bioMerieux, Fujirebio, Grifols, Ortho Clinical Diagnostics/J&J, Roche, ...
January 2017
2017-2021 Italy HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares, Country Segment Volume and Sales Forecasts
US$ 1,305.00
... and sale forecasts for HIV-1/2/Combo, HIV Ag, NAT, Western Blot and other confirmatory assays performed in the following market segments: Hospitals ... sales and market share estimates for major suppliers of AIDS tests, including Abbott, bioMerieux, Bio-Rad, DiaSorin, Grifols, Ortho Clinical Diagnostics/J&J, ...
January 2017
2017-2021 Germany HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares, Country Segment Volume and Sales Forecasts
US$ 1,305.00
... and sale forecasts for HIV-1/2/Combo, HIV Ag, NAT, Western Blot, and other confirmatory assays performed in the following market segments: Hospitals ... and market share estimates for major suppliers of AIDS tests, including Abbott, Biotest, bioMerieux, Bio-Rad, DiaSorin, Grifols, Ortho Clinical Diagnostics/J&J, ...
January 2017
2017-2021 France HIV/AIDS Diagnostics Market: HIV 1/2, Combo, Ag, NAT, Western Blot--Supplier Shares, Country Segment Volume and Sales Forecasts
US$ 1,305.00
... sale forecasts for HIV-1/2/Combo, HIVAg, NAT, Western Blot, and other confirmatory assays performed in the following market segments: Hospitals ... sales and market share estimates for major suppliers of AIDS tests, including Abbott, Biotest, bioMerieux, Bio-Rad, Grifols, Ortho Clinical Diagnostics/J&J, Roche ...
January 2017
2017-2021 Diagnostic Imaging: X-Ray, Ultrasound, CT, MRI, PACS, PET, Nuclear Medicine--Modality and Geographic Region Segment Forecasts, Trends and Outlook
US$ 2,565.00
... demographic and social trends with potentially significant impact on the diagnostic imaging industry during the next five years. Analysis of major ... North America, Europe, Japan and Latin America. Discussion of trends in X-ray, ultrasound, MRI, CT, nuclear medicine, PET, PACS and other technologies. Contains ...
January 2017
34 pages
2017-2021 Orthopedics: Reconstructive, Spinal, Trauma, Biologics, Arthroscopy, Soft Goods, Dental--Segment and Geographic Region Forecasts, Trends and Outlook
US$ 2,565.00
... U. S. and international trends with potentially significant impact on the orthopedics market during the next five years, including industry ... of major market segments, including reconstructive devices, fracture fixation products, arthroscopy, soft tissue repair, spinal implants and instrumentation, bone ...
January 2017
34 pages
